David Henry Mack - 13 Aug 2024 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ Robert Ticktin, by power of attorney
Issuer symbol
PMVP
Transactions as of
13 Aug 2024
Net transactions value
$0
Form type
4
Filing time
03 Oct 2024, 16:44:08 UTC
Previous filing
22 Jan 2024
Next filing
22 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Disposed to Issuer -134,584 -100% 0 13 Aug 2024 Common Stock 134,584 $28.33 Direct F1, F2
transaction PMVP Employee Stock Option (right to buy) Disposed to Issuer -249,600 -100% 0 13 Aug 2024 Common Stock 249,600 $16.29 Direct F3, F4
transaction PMVP Employee Stock Option (right to buy) Award +384,184 384,184 13 Aug 2024 Common Stock 384,184 $1.48 Direct F2, F4, F5
transaction PMVP Employee Stock Option (right to buy) Disposed to Issuer -330,000 -100% 0 13 Aug 2024 Common Stock 330,000 $5.70 Direct F6, F7
transaction PMVP Employee Stock Option (right to buy) Award +330,000 330,000 13 Aug 2024 Common Stock 330,000 $1.48 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021.
F2 On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 134,584 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 134,584 shares, having an exercise price of $1.48 per share.
F3 Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.
F4 On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 249,600 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 249,600 shares, having an exercise price of $1.48 per share.
F5 One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter.
F6 Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.
F7 On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 330,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 330,000 shares, having an exercise price of $1.48 per share.
F8 One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter.